Shirley L. Markant
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 2%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Robert J. Wechsler‐ReyaAlfred L. GoldbergTracy‐Ann ReadTomo ŠarićKenneth L. RockShih‐Chung ChangAkira HattoriIan A. York
- Topics
- Hedgehog Signaling Pathway Studies (8 papers)Epigenetics and DNA Methylation (6 papers)Glioma Diagnosis and Treatment (3 papers)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Shirley L. Markant
11 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 1.1k
- Oncology 468
- Genetics 380
- Immunology 361
- Cancer Research 198
Countries citing papers authored by Shirley L. Markant
This map shows the geographic impact of Shirley L. Markant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley L. Markant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley L. Markant more than expected).
Fields of papers citing papers by Shirley L. Markant
This network shows the impact of papers produced by Shirley L. Markant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley L. Markant. The network helps show where Shirley L. Markant may publish in the future.
Co-authorship network of co-authors of Shirley L. Markant
This figure shows the co-authorship network connecting the top 25 collaborators of Shirley L. Markant. A scholar is included among the top collaborators of Shirley L. Markant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirley L. Markant. Shirley L. Markant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 46 | |
| 3 | 18 | |
| 4 | 24 | |
| 5 | 97 | |
| 6 | 16 | |
| 7 | 279 | |
| 8 | 8 | |
| 9 | 470 | |
| 10 | 113 | |
| 11 | 430 |
About Shirley L. Markant
Shirley L. Markant is a scholar working on Genetics, Oncology and Molecular Biology, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (8 papers), Epigenetics and DNA Methylation (6 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (380 citations), Developmental Neuroscience (109 citations) and Oncology (468 citations). Shirley L. Markant has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Robert J. Wechsler‐Reya, Alfred L. Goldberg, Tracy‐Ann Read, Tomo Šarić, Kenneth L. Rock, Shih‐Chung Chang, Akira Hattori, Ian A. York, Masafumi Tsujimoto and Jessica D. Kessler. Their work appears in journals such as The EMBO Journal, Nature Immunology and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.